Document is current
Any future updates will be listed below
-
Authors
Cramer, Avilash K. https://orcid.org/0000-0003-0014-8921
Plana, Deborah https://orcid.org/0000-0002-4218-1693
Yang, Helen https://orcid.org/0000-0002-9455-5300
Carmack, Mary M. https://orcid.org/0000-0003-4546-790X
Tian, Enze https://orcid.org/0000-0001-6410-5360
Sinha, Michael S. https://orcid.org/0000-0002-9165-8611
Krikorian, David
Turner, David
Mo, Jinhan
Li, Ju https://orcid.org/0000-0002-7841-8058
Gupta, Rajiv https://orcid.org/0000-0002-5882-960X
Manning, Heather
Bourgeois, Florence T. https://orcid.org/0000-0001-7798-4560
Yu, Sherry H. https://orcid.org/0000-0002-1432-9128
Sorger, Peter K. https://orcid.org/0000-0002-3364-1838
LeBoeuf, Nicole R. https://orcid.org/0000-0002-8264-834X
-
Funding
Funding for this research was provided by:
National Cancer Institute (P30-CA006516)
National Institutes of Health (T32-GM007753)
- License Information
-
More Information
Article History
Received: 8 June 2020
Accepted: 9 December 2020
First Online: 21 January 2021
Competing interests
: All authors have completed the ICMJE uniform disclosure form at and declare: no support from any organization for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. PKS is a member of the SAB or Board of Directors of Applied Biomath, Glencoe Software and RareCyte Inc and has equity in these companies. In the last five years the Sorger lab has received research funding from Novartis and Merck. Sorger declares that none of these relationships are directly or indirectly related to the content of this manuscript. NRB is a consultant for or has received honoraria from the following companies: Seattle Genetics, Sanofi, and Bayer. The authors have no affiliation with and received no compensation from TOMI Environmental Solutions, Inc and TOMI played no role in the design of the study. The authors corresponded with members of TOMI Corporation concerning the technical specifications of the SteraMist system. The other authors have no competing interests or interests that could be perceived to influence the results and/or discussion reported in this paper.
